TABLE 2.
Diagnostic and laboratory findings for 25 reported cases of Baylisascaris procyonis neural and visceral larva migransa
| Patient no./yrb/sex/age/location | Funduscopic exam result | Blood eosinophilia (%) | CSF eosinophilia (%) | Serology for B. procyonisc | Chest radiography result | Reference(s) |
|---|---|---|---|---|---|---|
| 1/1973/F/18 mos/Missouri | NR | 30 | 49, 80, 34, 100 | Positive for Ascaris by bentonite flocculation, S = 1:160, C = 1:10 | Mild right perihilar infiltrate | 5, 7, 8, 13 |
| 2/1980/M/10 mos/Pennsylvania | Optic atrophy later | 27 | 68 | S = strong positive by IFA | NR | 5–8, 34 |
| 3/1984/M/18 mos/Illinois | Normal | 37, 34 | NR, 50, 80 | S = positive by IFA and later by ELISA, S = 1.635d | Normal | 5–8, 35 |
| 4/∼1985/M/21 yrs/Oregon | NR | NR | NR | S = positive by ELISA, 1.800 | NR | 5, 6, 7, 33; K. D. Thomson, unpublished data and written communication to K. R. Kazacos (2005, 2010) |
| 5/1990/M/13 mos/New York | Normal | 39 | 60, 52 | Positive by EIA (Western blotting; S = >1:10, 240, C = 1:40–80) and later by ELISA (S = 2.600–2.961, C = 1.655–1.689) | Normal | 5–8, 33 |
| 6/1993/M/13 mos/California | R, diffusely mottled retina, reddish macular lesion, optic pallor | 45 | Prominent eosinophilia | S = positive by IFA (1:1,024) and ELISA (0.809, 1:102, 400) | Mild bihilar and right middle lobe infiltrates | 5–8, 36 |
| 7/1993/M/9 mos/Michigan | Normal | 29, 33, 43, 40 | many eosinophils, 85, 89, 62, 71 | S = positive by ELISA, 3.113 | Normal | 5, 6, 8; J. M. Proos and C. Gushurst, unpublished data (1993) and written communication to K. R. Kazacos (1993–1994) |
| 8/∼1994/M/10 yrs/Massachusetts | ND | 15 | ND | ND | NR | 5, 7, 8, 37 |
| 9/1996/M/6 yrs/Illinois | L, DUSN | 5 (post-3.5 yrs) | 6 (post-3.5 yrs) | Positive later by IFA (S = 1:4,096, C = 1:64) and by ELISA (S = 2.230, C = 1.114) | NR | 5–8, 38 |
| 10/1996/M/13 mos/Minnesota | Normal | 35, 14, 12 | 54, 73, 4, 6 | Positive by IFA (S = 1:1,024–4,096; C = 1:64) and by ELISA (S = 1.361, C = 0.438, 1.333) | NR | 5–8, 39 |
| 11/1997/M/19 mos/Minnesota | Normal | 18, 22, 22, 26 | 4, 19, 13, 5, 67 | Positive by IFA (S = 1:4,096, C = 1:64–256) and by ELISA (S = 2.316, C = 0.289–0.795) | NR; CT normal | 5–8, 39 |
| 12/1998/M/11 mos/California | R, DUSN, with chorioretinal scarring, linear track lesions, optic atrophy | 17, 17 | 6, 7 | Positive by IFA (S = 1:64–1,024, C = 1:64) and by ELISA (S = 1.334, 2.574, C = 0.128) | NR | 5–8, 40 |
| 13/2000/M/2.5 yrs/Illinois | R, Multifocal choroiditis with infiltrates | 28, 6 | 32, 26 | Positive by IFA (S = 1:1,024–4,096, C = 1:1,024) and by ELISA (S = 3.132–3.218, C = 1.888, 2.021) | Normal | 5–8, 38, 41 |
| 14/2000/M/17 yrs/California | ND | 15 | 37, 42 | Positive by IFA (S = 1:4,096, C = 1:256) and by ELISA (S = 3.025, 3.035, C = 1.746, 1.765) | ND | 5–8, 41; W. A. Kennedy, unpublished data (2001) and written communication to K. R. Kazacos (2001) |
| 15/2002/M/11 mos/California | Normal | 30, 30 | 23, 54, 33 | Positive by ELISA, S = 1.869, 2.451, C = 0.624–1.017 | ND | 5–8; K. R. Kazacos, unpublished data (2002–2004); D. Paul, unpublished data (2003) and written communication to K. R. Kazacos (2003) |
| 16/2004/M/4 yrs/Louisiana | NR | 12 | 55 | Positive by ELISA, S = 0.547, 0.976 | NR | 42 |
| 17/2004/F/15 mos/New York | NR | Marked eosinophilia | Eosinophilia | Positive by ELISA, S = 1.921–2.556, C = 0.175, 0.347 | NR | 43; C. J. Crosley, unpublished data (2004) and written communication to K. R. Kazacos (2004) |
| 18/2005/M/7 yrs/Ontario | Bilateral patchy subretinal infiltrates | 24, 21, 8 | 30, 7 | Positive by ELISA (S = 1.813, C = 0.186, 0.723) and by Western blotting | NR | 8, 44 |
| 19/2007/M/17 yrs/Oregon | Bilateral subtle edema of optic discs | 8, 21 | 49, 39 | Positive by ELISA (S = 2.376, C = 0.600) and by Western blotting | Normal | 45 |
| 20/2007/F/18 mos/Missouri | NR | Profound eosinophilia | 40 | Positive by ELISA (S = 2.130, 2.164, C = 1.919) and by Western blotting | NR | 46; M. A. Jackson, unpublished data (2007) and written communication to K. R. Kazacos (2007) |
| 21/2008/M/12 mos/New York | Normal | 30, 24 | 29, 46, 19 | Positive by ELISA, S = 1.385, C = 1.453 | Normal | 47 |
| 22/2008/M/14 mos/Massachusetts | Normal | 24, 10, 4 | 24 | S = Positive by ELISA with rising titer (0.243–0.500) and by Western blotting | NR | 48, 49 |
| 23/2008/M/14 mos/Ontario | Normal | 32 | NR | Positive by ELISA (S = 0.744, C = neg) and by Western blotting | NR | 50 |
| 24/2009/M/54 yrs/Missouri | NR | NR | Normal | ND | NR | 51; M. Cohen, unpublished data (2009) and written communication to K. R. Kazacos (2011) |
| 25/NR/F/73 yrs/British Columbia | NR | NR | NR | ND | NR | 52 |
CSF; cerebrospinal fluid; R, right eye; L, left eye; NR, not reported; ND, not done; IFA, indirect immunofluorescence assay; ELISA, enzyme-linked immunosorbent assay; DUSN, diffuse unilateral subacute neuroretinitis; EIA, enzyme immunoassay; CT, computed tomography; neg, negative.
yr, year of onset or presentation.
Data include unpublished ELISA results from K. R. Kazacos. S, serum; C, CSF.
For ELISA, the value is the optical density (OD) reading, where an OD of >0.250 is considered positive for serum.